Segment Reporting (Tables)

6 Months Ended

Jun. 30, 2013

Segment Reporting (Tables) [Abstract]

Segment Reporting Information By Segment

A reconciliation of the totals reported for the reportable segments to the applicable line items in our accompanying unaudited condensed consolidated statements of operations is as follows:

	Three Months Ended June 30,						Six Months Ended June 30,
(in millions)	2013			2012*			2013			2012*
Net sales
Interventional Cardiology	$	537		$	551		$	1,050		$	1,149
Peripheral Interventions	205			196			400			384
Cardiovascular	742			747			1,450			1,533
Cardiac Rhythm Management	485			494			970			998
Electrophysiology	37			37			72			74
Rhythm Management	522			531			1,042			1,072
Endoscopy	334			309			647			607
Urology/Women's Health	126			125			245			243
Neuromodulation	111			92			200			175
MedSurg	571			526			1,092			1,025
Net sales allocated to reportable segments	1,835			1,804			3,584			3,630
Sales generated from divested businesses	19			31			55			60
Impact of foreign currency fluctuations	(45		)	(7		)	(69		)	4
	$	1,809		$	1,828		$	3,570		$	3,694
Income (loss) before income taxes
Cardiovascular	$	194		$	195		$	364		$	386
Rhythm Management	61			77			124			160
MedSurg	183			150			333			283
Operating income allocated to reportable segments	438			422			821			829
Corporate expenses and currency exchange	(77		)	(71		)	(146		)	(155		)
Goodwill and other intangible asset impairment charges; and acquisition-, divestiture-, restructuring-, and litigation related charges and credits	(40		)	(3,839		)	(580		)	(3,869		)
Amortization expense	(101		)	(99		)	(204		)	(195		)
Operating (loss) income	220			(3,587		)	(109		)	(3,390		)
Other expense, net	(68		)	(31		)	(133		)	(105		)
Income (loss) before income taxes	$	152		$	(3,618	)	$	(242	)	$	(3,495	)

* We have restated prior year detail to conform to current year presentation.